Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10592099rdf:typepubmed:Citationlld:pubmed
pubmed-article:10592099lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:10592099lifeskim:mentionsumls-concept:C0007082lld:lifeskim
pubmed-article:10592099lifeskim:mentionsumls-concept:C0005953lld:lifeskim
pubmed-article:10592099lifeskim:mentionsumls-concept:C0229664lld:lifeskim
pubmed-article:10592099lifeskim:mentionsumls-concept:C0035379lld:lifeskim
pubmed-article:10592099lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:10592099lifeskim:mentionsumls-concept:C0032520lld:lifeskim
pubmed-article:10592099lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:10592099lifeskim:mentionsumls-concept:C0205221lld:lifeskim
pubmed-article:10592099pubmed:issue12lld:pubmed
pubmed-article:10592099pubmed:dateCreated1999-12-28lld:pubmed
pubmed-article:10592099pubmed:abstractTextThis study evaluated the specificity and sensitivity of the reverse transcriptase/polymerase chain reaction (RT-PCR) for carcinoembryonic antigen (CEA) for identification of breast tumour cells in bone marrow and in peripheral blood. Using one primer set from the A2/B3 domains of CEA with five to seven mismatches to other CEA-family members allowed reproducible detection of 1 colon tumour cell and 10 breast tumour cells in 10(7) mononuclear cells. Bone marrow samples from 181 patients with breast cancer were analysed by CEA-RT-PCR; 50 of these samples were analysed in parallel by routine immunocytochemistry. CEA-mRNA-positive bone marrow cells were found in 27.6% of the patients (50/181) with breast cancer. Five immunocytochemistry-positive samples were negative when analysed by CEA-RT-PCR. Limiting factors in the detection of micrometastatic breast tumour cells by CEA-RT-PCR are the heterogeneity of the tumour cells and the deficient expression of CEA in some of these cells. However, CEA-RT-PCR using the specific primer could detect 1 colon tumour cell in 1 x 10(7) normal peripheral blood mononuclear cells.lld:pubmed
pubmed-article:10592099pubmed:languageenglld:pubmed
pubmed-article:10592099pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10592099pubmed:citationSubsetIMlld:pubmed
pubmed-article:10592099pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10592099pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10592099pubmed:statusMEDLINElld:pubmed
pubmed-article:10592099pubmed:monthDeclld:pubmed
pubmed-article:10592099pubmed:issn0171-5216lld:pubmed
pubmed-article:10592099pubmed:authorpubmed-author:ThompsonJJlld:pubmed
pubmed-article:10592099pubmed:authorpubmed-author:KaulSSlld:pubmed
pubmed-article:10592099pubmed:authorpubmed-author:BastertGGlld:pubmed
pubmed-article:10592099pubmed:authorpubmed-author:EichlerAAlld:pubmed
pubmed-article:10592099pubmed:authorpubmed-author:ZhongX YXYlld:pubmed
pubmed-article:10592099pubmed:issnTypePrintlld:pubmed
pubmed-article:10592099pubmed:volume125lld:pubmed
pubmed-article:10592099pubmed:ownerNLMlld:pubmed
pubmed-article:10592099pubmed:authorsCompleteYlld:pubmed
pubmed-article:10592099pubmed:pagination669-74lld:pubmed
pubmed-article:10592099pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:10592099pubmed:meshHeadingpubmed-meshheading:10592099...lld:pubmed
pubmed-article:10592099pubmed:meshHeadingpubmed-meshheading:10592099...lld:pubmed
pubmed-article:10592099pubmed:meshHeadingpubmed-meshheading:10592099...lld:pubmed
pubmed-article:10592099pubmed:meshHeadingpubmed-meshheading:10592099...lld:pubmed
pubmed-article:10592099pubmed:meshHeadingpubmed-meshheading:10592099...lld:pubmed
pubmed-article:10592099pubmed:meshHeadingpubmed-meshheading:10592099...lld:pubmed
pubmed-article:10592099pubmed:meshHeadingpubmed-meshheading:10592099...lld:pubmed
pubmed-article:10592099pubmed:meshHeadingpubmed-meshheading:10592099...lld:pubmed
pubmed-article:10592099pubmed:meshHeadingpubmed-meshheading:10592099...lld:pubmed
pubmed-article:10592099pubmed:meshHeadingpubmed-meshheading:10592099...lld:pubmed
pubmed-article:10592099pubmed:meshHeadingpubmed-meshheading:10592099...lld:pubmed
pubmed-article:10592099pubmed:year1999lld:pubmed
pubmed-article:10592099pubmed:articleTitleEvaluation of the reverse transcriptase/polymerase chain reaction for carcinoembryonic antigen for the detection of breast cancer dissemination in bone marrow and peripheral blood.lld:pubmed
pubmed-article:10592099pubmed:affiliationLaboratory of Oncology, Department of Obstetrics and Gynaecology, University Hospital, Heidelberg, Germany. Zhong@ubaclu.unibas.chlld:pubmed
pubmed-article:10592099pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10592099lld:pubmed